<p>Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect</p>
Shouyi Wu(Lanzhou University Second Hospital), Zhi Huang(Changsha University of Science and Technology), Chuanjie Wu(Capital Medical University), Yuhan Wang(Guangzhou University of Chinese Medicine), Haifeng Zhang(Jiangsu Province Hospital), Yuan Chen(Johns Hopkins University), Shuang Li(Chengdu Medical College), Yajun Lian(First Affiliated Hospital of Zhengzhou University), Yake Zheng(First Affiliated Hospital of Zhengzhou University), Wenchao Cheng(First Affiliated Hospital of Zhengzhou University)
Cited by 21
Related Papers
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events
|Journal of the American College of Cardiology|2016|354
Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial
|Cephalalgia|2012|217